These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38392856)

  • 61. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
    Khanna S
    J Intern Med; 2021 Aug; 290(2):294-309. PubMed ID: 33856727
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Omadacycline and
    Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
    Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging alternatives against Clostridioides difficile infection.
    Romero-Rodríguez A; Martínez de la Peña C; Troncoso-Cotal S; Guzmán C; Sánchez S
    Anaerobe; 2022 Dec; 78():102638. PubMed ID: 36210608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reducing Recurrence and Complications Related to Clostridioides difficile Infection: A Panel Discussion Summary.
    Perez R; Khanna S; Tillotson GS; Lett JE; Prince MA; Lattimer C
    Prof Case Manag; 2022 Nov-Dec 01; 27(6):277-287. PubMed ID: 36206121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bacteriophage endolysins as a potential weapon to combat
    Mondal SI; Draper LA; Ross RP; Hill C
    Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
    [No Abstract]   [Full Text] [Related]  

  • 68. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
    Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implementation of a Structured Process for Clinically Indicated Testing for
    Kusma M; Little J; Kociolek L
    J Pediatr Hematol Oncol Nurs; 2023; 40(3):188-194. PubMed ID: 36691391
    [No Abstract]   [Full Text] [Related]  

  • 70. Pediatric Clostridioides difficile Infection: Diagnosis and Diagnostic Stewardship.
    Schwenk HT; Pollock NR; Vaughan-Malloy AM
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S16-S21. PubMed ID: 34791395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanisms and impact of antimicrobial resistance in Clostridioides difficile.
    Dureja C; Olaitan AO; Hurdle JG
    Curr Opin Microbiol; 2022 Apr; 66():63-72. PubMed ID: 35077947
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clostridioides difficile epidemiology in India.
    Monaghan TM; Biswas R; Satav A; Ambalkar S; Kashyap RS
    Anaerobe; 2022 Apr; 74():102517. PubMed ID: 35063600
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019-2020
    Ramirez JA; Angulo FJ; Carrico RM; Furmanek S; Oliva SP; Zamparo JM; Gonzalez E; Zhang P; Parrish LAW; Marimuthu S; Pride MW; Gray S; Matos Ferreira CS; Arnold FW; Istúriz RE; Minarovic N; Moïsi JC; Jodar L
    Emerg Infect Dis; 2023 May; 29(5):919-928. PubMed ID: 37080953
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanisms of antibiotic resistance of Clostridioides difficile.
    Wickramage I; Spigaglia P; Sun X
    J Antimicrob Chemother; 2021 Nov; 76(12):3077-3090. PubMed ID: 34297842
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile.
    Pokhrel A; Poudel A; Castro KB; Celestine MJ; Oludiran A; Rinehold AJ; Resek AM; Mhanna MA; Purcell EB
    J Bacteriol; 2020 Sep; 202(19):. PubMed ID: 32661079
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.